Olanzapine (2015-02-18)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| C302667 | B. Olanzapine 5 mg | - Recalling Firm
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- CANADA
- Marketing Authorization Holder
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- CANADA
| Tablet | DIN 02311976 | Olanzapine 5 mg |
| C302669 | C. Olanzapine 10 mg | - Recalling Firm
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- CANADA
- Marketing Authorization Holder
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- CANADA
| Tablet | DIN 02311992 | Olanzapine 10 mg |
| C302666 | A. Olanzapine 2.5 mg | - Recalling Firm
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- CANADA
- Marketing Authorization Holder
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- CANADA
| Tablet | DIN 02311968 | Olanzapine 2.5 mg |
Recalled Products
A. Olanzapine 2.5 mg
B. Olanzapine 5 mg
C. Olanzapine 10 mg
This lot is potentially contaminated with foreign tablets (Ondansetron 8mg).